BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29405153)

  • 1. Effect of Interleukin-28B polymorphism on Interleukin-28 expression and immunological recovery amongst HIV-1-infected individuals following antiretroviral therapy.
    Srinidhi BV; Fletcher GJ; Sachidanantham J; Rupali P; Ramalingam VV; Demosthenes JP; Abraham OC; Pulimood SA; Rebekah G; Kannangai R
    Indian J Med Microbiol; 2017; 35(4):580-584. PubMed ID: 29405153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.
    Rajasuriar R; Booth D; Solomon A; Chua K; Spelman T; Gouillou M; Schlub TE; Davenport M; Crowe S; Elliott J; Hoy J; Fairley C; Stewart G; Cameron P; Lewin SR
    J Infect Dis; 2010 Oct; 202(8):1254-64. PubMed ID: 20812848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of interleukin-28B rs12979860 and rs8099917 polymorphisms with sustained viral response in hepatitis C virus genotype 1 and 3 infected patients from the Indian subcontinent.
    Ranjan P; Fletcher GJ; Radhakrishnan M; Sivakumar J; Premkumar PS; Goel A; Zachariah UG; Abraham P
    Indian J Med Microbiol; 2016; 34(3):335-41. PubMed ID: 27514956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients.
    Derbala M; Rizk NM; Al-Kaabi S; John A; Sharma M; El-dweik N; Yakoob R; Pasic F; Almohanadi M; Alejji K; Abdelmola A; Butt M
    Virology; 2013 Sep; 444(1-2):292-300. PubMed ID: 23866096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 28B rs12979860 (CT/TT) genotype is associated with milder hepatic damage in the natural evolution of HCV/HIV coinfection.
    de la Fuente C; Hinojosa C; Gilabert I; Jiménez Sousa MÁ; González JM; Ortiz de Lejarazu R; Loma A; Nieto C; Arnaiz R; Bermejo-Martin JF
    J Interferon Cytokine Res; 2013 Jan; 33(1):43-7. PubMed ID: 23030669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of ABCB-1 C3435T polymorphisms on plasma nevirapine and efavirenz levels and their effects on virologic and immunological outcomes in HIV/TB co-infected Thai adults under anti-retroviral therapy.
    Uttayamakul S; Likanonsakul S; Manosuthi W; Wichukchinda N; Shioda T; Khusmith S
    Southeast Asian J Trop Med Public Health; 2012 Jan; 43(1):78-88. PubMed ID: 23082557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL18 gene polymorphism and its influence on CD4+ T-cell recovery in HIV-positive patients receiving antiretroviral therapy.
    Andrade-Santos JL; Carvalho-Silva WHV; Coelho AVC; Souto FO; Crovella S; Brandão LAC; Guimarães RL
    Infect Genet Evol; 2019 Nov; 75():103997. PubMed ID: 31401307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 28B rs12979860 genotype and Human Immunodeficiency Virus type 1: Susceptibility, AIDS development and therapeutic outcome.
    Zaidane I; Wakrim L; Oulad Lahsen A; Bensghir R; Chihab H; Jadid FZ; El Fihry R; Lamdini H; Fayssel N; Marhoum El Filali K; Oudghiri M; Benjelloun S; Ezzikouri S
    Hum Immunol; 2018 Jan; 79(1):70-75. PubMed ID: 29080719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon lambda rs368234815 ΔG/ΔG is associated with higher CD4
    Freitas IT; Tinago W; Sawa H; McAndrews J; Doak B; Prior-Fuller C; Sheehan G; Lambert JS; Muldoon E; Cotter AG; Hall WW; Mallon PWG; Carr MJ
    AIDS Res Ther; 2020 Apr; 17(1):13. PubMed ID: 32295609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of Interleukin 28B rs12979860 and rs8099917 Polymorphisms and T-helper 1 Response in Hepatitis C Virus Patients.
    Ea R; Aa G; Ag ES; Ma A
    Egypt J Immunol; 2015 Jun; 22(2):57-68. PubMed ID: 28502145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL28B gene polymorphisms and Th1/Th2 cytokine levels might be associated with HTLV-associated arthropathy.
    de Sá KS; Santana BB; de Souza Ferreira TC; Sousa RC; Caldas CA; Azevedo VN; Feitosa RN; Machado LF; de Oliveira Guimarães Ishak M; Ishak R; Vallinoto AC
    Cytokine; 2016 Jan; 77():79-87. PubMed ID: 26546777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-8 Alterations in HIV-1 Infected Children With Disease Progression.
    Pananghat AN; Aggarwal H; Prakash SS; Makhdoomi MA; Singh R; Lodha R; Ali S; Srinivas M; Das BK; Pandey RM; Kabra SK; Luthra K
    Medicine (Baltimore); 2016 May; 95(21):e3734. PubMed ID: 27227934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide association of IL-28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C in a Tunisian population.
    Bizid S; Bouali R; Ouedrani A; Mrabet A; Ben Abdallah H; Ghazouani E; Abdelli N
    Tunis Med; 2016 Jan; 94(1):6-11. PubMed ID: 27525598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL7RA polymorphisms predict the CD4+ recovery in HIV patients on cART.
    Guzmán-Fulgencio M; Berenguer J; Jiménez-Sousa MA; Micheloud D; García-Álvarez M; Bellón JM; Aldámiz-Echevarría T; García-Broncano P; Catalán P; Diez C; Pineda-Tenor D; Resino S
    Eur J Clin Invest; 2015 Nov; 45(11):1192-9. PubMed ID: 26402121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.
    Serrano-Villar S; Sainz T; Lee SA; Hunt PW; Sinclair E; Shacklett BL; Ferre AL; Hayes TL; Somsouk M; Hsue PY; Van Natta ML; Meinert CL; Lederman MM; Hatano H; Jain V; Huang Y; Hecht FM; Martin JN; McCune JM; Moreno S; Deeks SG
    PLoS Pathog; 2014 May; 10(5):e1004078. PubMed ID: 24831517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of polymorphisms in the HCP5 and HLA-C, and ZNRD1 genes on HIV viral load.
    Thørner LW; Erikstrup C; Harritshøj LH; Larsen MH; Kronborg G; Pedersen C; Larsen CS; Pedersen G; Gerstoft J; Obel N; Ullum H
    Infect Genet Evol; 2016 Jul; 41():185-190. PubMed ID: 27083073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
    Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
    AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of polymorphisms in interferon λ 3 (interleukin 28B) on sustained virologic response to therapy in patients with chronic hepatitis D virus infection.
    Yilmaz E; Baran B; Soyer OM; Onel M; Onel D; Ormeci AC; Gokturk S; Evirgen S; Akyuz F; Demir K; Besisik F; Kaymakoglu S; Karaca C
    Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1753-8. PubMed ID: 24582569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune signatures for HIV-1 and HIV-2 induced CD4
    Salwe S; Singh A; Padwal V; Velhal S; Nagar V; Patil P; Deshpande A; Patel V
    BMC Infect Dis; 2019 Feb; 19(1):135. PubMed ID: 30744575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.
    DaFonseca S; Niessl J; Pouvreau S; Wacleche VS; Gosselin A; Cleret-Buhot A; Bernard N; Tremblay C; Jenabian MA; Routy JP; Ancuta P
    Retrovirology; 2015 Apr; 12():38. PubMed ID: 25924895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.